Cutaneous T-cell lymphoma: centuries of controversy.
Two hundred years have passed since the description of mycosis fungoides by Alibert. During this time, the disease has been the focus of intense controversy and research, with these two intimately intertwined. In this article, the major components of the controversies surrounding cutaneous T-cell lymphoma are examined. The next millenium will see the resolution of these controversies and the fruition of continued research into this condition.
Duncan
K
K
Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
Heald
P
P
D000075202:Contraindications; D003937:Diagnosis, Differential; D004358:Drug Therapy / Q000379:methods; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000502:physiology / Q000627:therapeutic use; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D009182:Mycosis Fungoides / Q000175:diagnosis / Q000628:therapy; D009367:Neoplasm Staging; D011701:PUVA Therapy; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*
D007155:Immunologic Factors